• FirefoxInstall the new Firefox »
  •  Dow Up 0.21% Nasdaq Up 0.32%

    Arena Pharmaceuticals, Inc. (ARNA)

    -NasdaqGS
    4.27 Down 0.05(1.16%) 2:21PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:4.32
    Open:4.33
    Bid:4.27 x 10400
    Ask:4.28 x 5500
    1y Target Est:6.90
    Beta:-4.12
    Earnings Date:May 11 - May 15 (Est.)
    Day's Range:4.23 - 4.40
    52wk Range:3.26 - 7.24
    Volume:3,152,464
    Avg Vol (3m):8,753,900
    Market Cap:940.68M
    P/E (ttm):N/A
    EPS (ttm):-0.28
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ARNA

    Comparison

    Symbol% ChgMkt Cap
    ARNADown 1.16%940.68M
    GSKDown 0.63%114.31B
    OREXDown 6.30%984.25M
    RHHBYDown 1.18%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):25.74
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.48
    Quarterly EPS Est (Mar-15) :-0.14
    Mean Recommendation*:2.7
    PEG Ratio (5 yr expected):0.45

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback